Follow
VIRGINIA RIVERO BUCETA
VIRGINIA RIVERO BUCETA
Investigador CIB
Verified email at cib.csic.es
Title
Cited by
Cited by
Year
Two new parameters based on distances in a receiver operating characteristic chart for the selection of classification models
A Pérez-Garrido, AM Helguera, F Borges, MNDS Cordeiro, V Rivero, ...
Journal of chemical information and modeling 51 (10), 2746-2759, 2011
612011
Hit to lead evaluation of 1, 2, 3-triazolo [4, 5-b] pyridines as PIM kinase inhibitors
J Pastor, J Oyarzabal, G Saluste, RM Alvarez, V Rivero, F Ramos, ...
Bioorganic & medicinal chemistry letters 22 (4), 1591-1597, 2012
502012
Imidazo[1,2-a]pyrazines as novel PI3K inhibitors
SM González, AI Hernández, C Varela, S Rodríguez-Arístegui, ...
Bioorganic & medicinal chemistry letters 22 (5), 1874-1878, 2012
412012
Unraveling the 17β-Estradiol Degradation Pathway in Novosphingobium tardaugens NBRC 16725
J Ibero, B Galán, V Rivero-Buceta, JL Garcia
Frontiers in Microbiology 11, 588300, 2020
322020
Anti-staphylococcal hydrogels based on bacterial cellulose and the antimicrobial biopolyester poly (3-hydroxy-acetylthioalkanoate-co-3-hydroxyalkanoate)
V Rivero-Buceta, MR Aguilar, AM Hernández-Arriaga, FG Blanco, A Rojas, ...
International Journal of Biological Macromolecules 162, 1869-1879, 2020
302020
Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor
SM González, AI Hernández, C Varela, S Rodríguez-Arístegui, M Lorenzo, ...
Bioorganic & medicinal chemistry letters 22 (10), 3460-3466, 2012
292012
From residues to added-value bacterial biopolymers as nanomaterials for biomedical applications
FG Blanco, N Hernández, V Rivero-Buceta, B Maestro, JM Sanz, A Mato, ...
Nanomaterials 11 (6), 1492, 2021
262021
Bioconversion of lignin-derived aromatics into the building block pyridine 2, 4-dicarboxylic acid by engineering recombinant Pseudomonas putida strains
H Gómez-Álvarez, P Iturbe, V Rivero-Buceta, P Mines, TDH Bugg, ...
Bioresource Technology 346, 126638, 2022
252022
Classifier Ensemble Based on Feature Selection and Diversity Measures for Predicting the Affinity of A2B Adenosine Receptor Antagonists
I Bonet, P Franco-Montero, V Rivero, M Teijeira, F Borges, E Uriarte, ...
Journal of chemical information and modeling 53 (12), 3140-3155, 2013
232013
When microbial biotechnology meets material engineering
AM Hernández‐Arriaga, C Campano, V Rivero‐Buceta, MA Prieto
Microbial Biotechnology 15 (1), 149-163, 2022
162022
Monomodular Pseudomonas aeruginosa phage JG004 lysozyme (Pae87) contains a bacterial surface-active antimicrobial peptide-like region and a possible substrate-binding subdomain
R Vázquez, M Seoane-Blanco, V Rivero-Buceta, S Ruiz, MJ van Raaij, ...
Acta Crystallographica Section D: Structural Biology 78 (4), 435-454, 2022
102022
Elevated c‐di‐GMP levels promote biofilm formation and biodesulfurization capacity of Rhodococcus erythropolis
P Dorado‐Morales, I Martínez, V Rivero‐Buceta, E Díaz, H Bähre, I Lasa, ...
Microbial Biotechnology 14 (3), 923-937, 2021
72021
Unraveling the 17β-estradiol degradation pathway in Novosphingobium tardaugens NBRC 16725. Front Microbiol 11: 588300
J Ibero, B Galán, V Rivero-Buceta, JL García
62020
Latest QSAR study of adenosine A receptor affinity of xanthines and deazaxanthines
A Pérez-Garrido, V Rivero-Buceta, G Cano, S Kumar, H Pérez-Sánchez, ...
Molecular diversity 19, 975-989, 2015
62015
Gaining control of bacterial cellulose colonization by polyhydroxyalkanoate-producing microorganisms to develop bioplasticized ultrathin films
C Campano, V Rivero-Buceta, MJ Fabra, MA Prieto
International journal of biological macromolecules 223, 1495-1505, 2022
52022
Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human adenosine receptor ligands
L Saíz-Urra, M Teijeira, V Rivero-Buceta, AM Helguera, M Celeiro, ...
Molecular diversity 20 (1), 55-76, 2016
32016
From residues to added-value bacterial biopolymers as nanomaterials for Biomedical Applications. Nanomaterials. 2021; 11: 1492
FG Blanco, N Hernández, V Rivero-Buceta, B Maestro, JM Sanz, A Mato, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
22021
Triazolo [4, 5-B] Pyridin Derivatives
JP Fernández, JO Santamarina, CGP Saluste, CB Aparicio, RMA Escobar, ...
US Patent App. 13/579,781, 2013
22013
Heterologous constitutive production of short-chain-length polyhydroxyalkanoates in Pseudomonas putida KT2440: the involvement of IbpA inclusion body protein
MT Manoli, FG Blanco, V Rivero-Buceta, R Kniewel, SH Alarcon, ...
Frontiers in Bioengineering and Biotechnology 11, 2023
12023
A model-driven approach to upcycling recalcitrant feedstocks in Pseudomonas putida by decoupling PHA production from nutrient limitation
MT Manoli, Á Gargantilla-Becerra, C del Cerro Sánchez, V Rivero-Buceta, ...
Cell Reports 43 (4), 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20